Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Roth

Showing results (301-310 of 396) with videos related to

Pageof 40
Sort By:
Sleep|May 29, 2023
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON TrialYves Dauvilliers, Thomas Roth, Richard Bogan, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 21, 2022
Assessing the genotoxicity and carcinogenicity of 2-chloroethanol through structure activity relationships and in vitro testing approachesAshley Allemang, Cathy Lester, Thomas Roth, et al.
The American Journal of Gastroenterology|September 1, 2005
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trialDavid A Johnson, William C Orr, Joseph A Crawley, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover studyMartin Scharf, Roberta Rogowski, Steven Hull, et al.
Sleep|April 12, 2007
Early CPAP use identifies subsequent adherence to CPAP therapyRohit Budhiraja, Sairam Parthasarathy, Christopher L Drake, et al.
Journal of Sleep Medicine and Disorders|March 21, 2020
The Anxiolytic Effects of Cognitive Behavior Therapy for Insomnia: Preliminary Results from a Web-delivered ProtocolVivek Pillai, Jason R Anderson, Philip Cheng, et al.
Plos One|June 19, 2015
Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer CellsMarkus Hecht, Sonja Erber, Thomas Harrer, et al.
Sleep|February 24, 2010
A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomniaSonia Ancoli-Israel, Andrew D Krystal, W Vaughn McCall, et al.
Sleep|June 3, 2017
Arousability and Fall Risk During Forced Awakenings From Nocturnal Sleep Among Healthy Males Following Administration of Zolpidem 10 mg and Doxepin 6 mg: A Randomized, Placebo-Controlled, Four-Way Crossover TrialChristopher L Drake, Heith Durrence, Philip Cheng, et al.
Psychopharmacology|February 25, 2014
Effects of alcohol hangover on simulated highway driving performanceJoris C Verster, Adriana C Bervoets, Suzanne de Klerk, et al.
Pageof 40

Showing results (301-310 of 396) with videos related to

Sort By:
Pageof 40
Sleep|May 29, 2023
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON TrialYves Dauvilliers, Thomas Roth, Richard Bogan, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 21, 2022
Assessing the genotoxicity and carcinogenicity of 2-chloroethanol through structure activity relationships and in vitro testing approachesAshley Allemang, Cathy Lester, Thomas Roth, et al.
The American Journal of Gastroenterology|September 1, 2005
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trialDavid A Johnson, William C Orr, Joseph A Crawley, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover studyMartin Scharf, Roberta Rogowski, Steven Hull, et al.
Sleep|April 12, 2007
Early CPAP use identifies subsequent adherence to CPAP therapyRohit Budhiraja, Sairam Parthasarathy, Christopher L Drake, et al.
Journal of Sleep Medicine and Disorders|March 21, 2020
The Anxiolytic Effects of Cognitive Behavior Therapy for Insomnia: Preliminary Results from a Web-delivered ProtocolVivek Pillai, Jason R Anderson, Philip Cheng, et al.
Plos One|June 19, 2015
Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer CellsMarkus Hecht, Sonja Erber, Thomas Harrer, et al.
Sleep|February 24, 2010
A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomniaSonia Ancoli-Israel, Andrew D Krystal, W Vaughn McCall, et al.
Sleep|June 3, 2017
Arousability and Fall Risk During Forced Awakenings From Nocturnal Sleep Among Healthy Males Following Administration of Zolpidem 10 mg and Doxepin 6 mg: A Randomized, Placebo-Controlled, Four-Way Crossover TrialChristopher L Drake, Heith Durrence, Philip Cheng, et al.
Psychopharmacology|February 25, 2014
Effects of alcohol hangover on simulated highway driving performanceJoris C Verster, Adriana C Bervoets, Suzanne de Klerk, et al.
Pageof 40